Syndax Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo.
SNDX Key Statistics
Stock Snapshot
The current Syndax Pharmaceuticals(SNDX) stock price is $18.49, with a market capitalization of 1.64B. The stock trades at a price-to-earnings (P/E) ratio of -6.53.
As of 2026-06-15, Syndax Pharmaceuticals(SNDX) stock has fluctuated between $18.04 and $18.60. The current price stands at $18.49, placing the stock +2.5% above today's low and -0.6% off the high.
The Syndax Pharmaceuticals(SNDX)'s current trading volume is 234.94K, compared to an average daily volume of 2.24M.
In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $25.59 and a 52-week low of $8.59.
In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $25.59 and a 52-week low of $8.59.
SNDX News
...
In June 2026, Syndax Pharmaceuticals reported that its all-oral Phase 1/2 SAVE trial regimen combining Revuforj (revumenib), decitabine/cedazuridine, and veneto...
Syndax Pharmaceuticals ( (SNDX) ) has shared an update. Syndax Pharmaceuticals filed a Current Report on Form 8-K that references information previously disclo...
Analyst ratings
100%
of 13 ratingsMore SNDX News
The latest announcement is out from Syndax Pharmaceuticals ( (SNDX) ). At its Annual Meeting held on June 10, 2026, Syndax Pharmaceuticals’ stockholders approv...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.